|
Market Closed -
Nasdaq
21:00:00 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 64.34 USD | -0.59% |
|
-9.29% | +8.96% |
| 10-07 | Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug | DJ |
| 10-07 | Tempus Expands Moderna, Merck Collaboration for Individualized Cancer Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.68B | - | ||||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- TEM Stock
- Charts Tempus AI, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
